+499.5%
MRNA vs RVMD
+430.6%
+68.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RVMD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.8% | -2.2% |
| 7D | +5.5% | +1.0% | +4.4% | +5.4% |
| 30D | +158.7% | +6.4% | +152.3% | +155.6% |
| 3M | +182.1% | +34.9% | +147.2% | +169.9% |
| 6M | +151.8% | +107.6% | +44.3% | +128.5% |
| YTD | +393.6% | +163.7% | +229.9% | +321.8% |
| 1Y | +499.5% | +439.2% | +60.3% | +322.4% |
| All | +499.5% | +430.6% | +68.8% | +322.4% |
Cumulative growth
Daily Returns
Daily percentage return beside RVMD.
Daily Out/Under-Performance
Portfolio return minus RVMD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RVMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RVMD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling